FUL
H.B. Fuller Company
NYSE · Basic Materials · Chemicals - Specialty · US
$53.78
+0.20%Year over year
Reported trailing growth
- Revenue
- -0.6%
- EBITDA
- +7.4%
- EBIT
- +17.7%
- EPS
- +795.9%
- Free cash flow
- +19.7%
- Operating cash flow
- +39.6%
Forward estimates
Based on analyst estimates
- Revenue
- +7.6%
- EBITDA
- +41.5%
- EPS
- +52.1%
Three-year CAGR
- Revenue
- -2.5%
- EBITDA
- +2.4%
- EBIT
- +7.4%
- Net income
- -5.5%
- EPS
- -6.2%
- Free cash flow
- -1.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of May 1, 2026